Zim Laboratories Appoints Cost Auditor for FY 2026-27

zim laboratories has appointed M/s Dhananjay V. Joshi & Associates as the Cost Auditor for the financial year 2026-27. The decision was taken by the Board of Directors at its meeting held on May 19, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The appointment is pursuant to Section 148 of the Companies Act, 2013. The Board meeting commenced at 12:45 p.m. (IST) and concluded at 4:30 p.m. (IST).

Details of the Appointment

The appointed firm, M/s Dhananjay V. Joshi & Associates, is a firm of Practicing Cost Accountants with a Firm Registration No. of 000030. The firm offers services in the domain of Cost and Management Accounting, Cost Audits, and other consultancy services. Its head office is situated in Pune, India.

Sr. No.	Particulars	Details
1.	Reason for change	Appointment of Cost Auditor pursuant to Section 148 of the Companies Act, 2013.
2.	Term of appointment	F.Y. 2026-27
3.	Brief profile	M/s Dhananjay V. Joshi & Associates is a firm of Practicing Cost Accountants (Firm Registration No.: 000030). They offer services in the domain of Cost and Management Accounting, Cost Audits and other consultancy. Their head office is situated in Pune, India.
4.	Disclosure of relationships	Not Applicable

The intimation regarding the appointment has been submitted to the stock exchanges for their records.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.16%	+3.20%	+18.76%	+43.36%	+12.75%	-8.78%

ZIM Laboratories has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Tuesday, May 19, 2026. The intimation was issued on May 12, 2026, under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The board meeting has been convened to, among other matters, consider and approve the Audited Financial Results of the company for the quarter and year ended March 31, 2026. The results will be reviewed on both a Standalone and Consolidated basis.

The key details of the scheduled board meeting are outlined below:

Parameter:	Details
Meeting Date:	Tuesday, May 19, 2026
Purpose:	Approval of Audited Financial Results (Standalone & Consolidated)
Period Under Review:	Quarter and year ended March 31, 2026
Regulation:	Regulation 29 of SEBI (LODR) Regulations, 2015
Intimation Date:	May 12, 2026

Trading Window Closure

In connection with the board meeting, ZIM Laboratories has also communicated the closure of its trading window in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's own Code of Conduct to Regulate, Monitor and Report Trading by Insiders.

The trading window closure details are as follows:

Parameter:	Details
Trading Window Closed From:	Wednesday, April 1, 2026
Trading Window Closed Until:	Thursday, May 21, 2026
Both Days:	Inclusive

The trading window restriction prohibits designated persons from dealing in the securities of ZIM Laboratories during the specified period. The window is set to reopen after May 21, 2026, following the conclusion of the board meeting and dissemination of financial results.

The intimation was signed by Piyush Nikhade, Company Secretary and Compliance Officer (Membership No. A38972), on behalf of ZIM Laboratories Limited.